Literature DB >> 22528566

Six cases of rare gene amplifications and multiple copy of fusion gene in childhood acute lymphoblastic leukemia.

Irén Haltrich1, Monika Csóka, Gábor Kovács, Dóra Török, Donát Alpár, Gábor Ottoffy, György Fekete.   

Abstract

Cytogenetic aberrations are very important factors in risk assessment of childhood hematological malignancies. We report six childhood acute lymphoid leukemia (ALL) cases with rare cytogenetic aberrations: five with RUNX1, ABL1 or MLL proto-oncogene amplification and one case of multiple copies of ETV6/RUNX1 fusion genes. The simultaneous presence of two adverse genetic aberrations is of special interest: ETV6-RUNX1 fusion gene is associated with good prognosis and intrachromosomal amplification of the homologue RUNX1 gene is associated with poor prognosis. We also report a patient with MLL amplification, a unique finding in childhood T-ALL. Report of these subtle rearrangements contributes to our understanding of diagnostic and prognostic significance of these rare cytogenetic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528566     DOI: 10.1007/s12253-012-9533-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

1.  Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.

Authors:  C Graux; J Cools; C Melotte; H Quentmeier; A Ferrando; R Levine; J R Vermeesch; M Stul; B Dutta; N Boeckx; A Bosly; P Heimann; A Uyttebroeck; N Mentens; R Somers; R A F MacLeod; H G Drexler; A T Look; D G Gilliland; L Michaux; P Vandenberghe; I Wlodarska; Peter Marynen; Anne Hagemeijer
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

2.  Amplification of the ABL gene in T-cell acute lymphoblastic leukemia.

Authors:  K E Barber; M Martineau; L Harewood; M Stewart; E Cameron; J C Strefford; S Rutherford; T D Allen; Z J Broadfield; K L Cheung; R L Harris; G R Jalali; A V Moorman; H M Robinson; C J Harrison
Journal:  Leukemia       Date:  2004-06       Impact factor: 11.528

Review 3.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

4.  Cytogenetic manifestation of chromosome 11 duplication/amplification in acute myeloid leukemia.

Authors:  Iveta Sárová; Jana Brezinová; Zuzana Zemanová; Silvia Izáková; Libuse Lizcová; Eva Malinová; Adéla Berková; Jaroslav Cermák; Jacqueline Maaloufová; Ludmila Nováková; Kyra Michalová
Journal:  Cancer Genet Cytogenet       Date:  2010-06

5.  AML1 gene over-expression in childhood acute lymphoblastic leukemia.

Authors:  F M Mikhail; K A Serry; N Hatem; Z I Mourad; H M Farawela; D M El Kaffash; L Coignet; G Nucifora
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

6.  Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.

Authors:  Anita Peter; Thomas Heiden; Tillmann Taube; Gabriele Körner; Karl Seeger
Journal:  Eur J Haematol       Date:  2009-07-06       Impact factor: 2.997

7.  Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

Authors:  Andishe Attarbaschi; Georg Mann; Renate Panzer-Grümayer; Silja Röttgers; Manuel Steiner; Margit König; Eva Csinady; Michael N Dworzak; Markus Seidel; Dasa Janousek; Anja Möricke; Carsten Reichelt; Jochen Harbott; Martin Schrappe; Helmut Gadner; Oskar A Haas
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 8.  ABL1 rearrangements in T-cell acute lymphoblastic leukemia.

Authors:  Anne Hagemeijer; Carlos Graux
Journal:  Genes Chromosomes Cancer       Date:  2010-04       Impact factor: 5.006

9.  RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.

Authors:  Anurita Peter Pais; Pratibha S Amare Kadam; Gauri Chandrakant Raje; Shripad Banavali; Purvish Parikh; Purna Kurkure; Brijesh Arora; Sumit Gujral; S Ashok Kumar; Y Badrinath
Journal:  Pediatr Hematol Oncol       Date:  2008-09       Impact factor: 1.969

10.  Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.

Authors:  A Quintás-Cardama; W Tong; T Manshouri; F Vega; P A Lennon; J Cools; D G Gilliland; F Lee; J Cortes; H Kantarjian; G Garcia-Manero
Journal:  Leukemia       Date:  2008-04-10       Impact factor: 11.528

View more
  3 in total

1.  Therapy-related pro-B cell acute lymphoblastic leukemia: report of two patients with MLL amplification.

Authors:  Frederick Racke; Carol Cole; Alison Walker; Jeffrey Jones; Nyla A Heerema
Journal:  Cancer Genet       Date:  2012-12-11

2.  Coexistence of iAMP21 and ETV6-RUNX1 fusion in an adolescent with B cell acute lymphoblastic leukemia: literature review of six additional cases.

Authors:  Jun Gu; Alexandra Reynolds; Lianghua Fang; Corrie DeGraffenreid; Kenneth Sterns; Keyur P Patel; L Jeffrey Medeiros; Pei Lin; Xinyan Lu
Journal:  Mol Cytogenet       Date:  2016-11-21       Impact factor: 2.009

3.  An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.

Authors:  C J Harrison; A V Moorman; C Schwab; A J Carroll; E A Raetz; M Devidas; S Strehl; K Nebral; J Harbott; A Teigler-Schlegel; M Zimmerman; N Dastuge; A Baruchel; J Soulier; M-F Auclerc; A Attarbaschi; G Mann; B Stark; G Cazzaniga; L Chilton; P Vandenberghe; E Forestier; I Haltrich; S C Raimondi; M Parihar; J-P Bourquin; J Tchinda; C Haferlach; A Vora; S P Hunger; N A Heerema; O A Haas
Journal:  Leukemia       Date:  2013-10-29       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.